Detalles de la búsqueda
1.
An open-label multiyear study of sargramostim-treated Parkinson's disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbers.
Transl Neurodegener
; 12(1): 26, 2023 05 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37217980
2.
Safety, tolerability, and immune-biomarker profiling for year-long sargramostim treatment of Parkinson's disease.
EBioMedicine
; 67: 103380, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-34000620
Resultados
1 -
2
de 2
1
Próxima >
>>